LIWANLI Innovation Co., Ltd. Stock Price

TWSE:3054 Community·NT$4.5b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Author Program NEW Create Narrative

3054 Share Price Performance

NT$56.00

32.05 (133.82%)

NT$56.00

32.05 (133.82%)

NT$56.00

Sun, 13 Sep 26

Share Pricen/a

3054 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

No trending discussion available.

Snowflake Analysis

Flawless balance sheet and good value.

1 Risk

2 Rewards

View Full Analysis

LIWANLI Innovation Co., Ltd. Key Details

Last Reported Earnings

Jun 30, 2026

Next Reporting Earnings

n/a

: 4.86
: 50.03%
: 94.47%
: 0%

View Full Analysis

About 3054

Founded: 1980
Employees: n/a
CEO: Li-Ching Chen
WebsiteView website: www.liwanli.com.tw

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for males, females, the elderly, and children. Its products include black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, e-soothing powder, tooth guard tablets, bovine and goat’s milk bites, bilberry tablets, drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is headquartered in Taipei, Taiwan.